Abstract P5-06-01: Homologous recombination deficiency (HRD) score predicts response to standard neoadjuvant chemotherapy in patients with triple negative or BRCA1/2 mutation-associated breast cancer

Melinda L Telli, William Audeh, Kirstin C Jensen, Shikha Bose, Kirsten Timms, Alexander Gutin, Victor Abkevich, Jerry Lanchbury, Chris Neff, Elisha Hughes, Zaina Sangale, Joshua Jones, Richard Wenstrup, Anne-Renee Hartman, Pei-Jen Chang, Shaveta Vinayak, James M Ford
  • April 2015, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1538-7445.sabcs14-p5-06-01

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1158/1538-7445.sabcs14-p5-06-01